Wenchang Yu
- Hepatology top 10%
- Pathology and Forensic Medicine
- Pulmonary and Respiratory Medicine
- Surgery
- Oncology
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (12 papers)Cancer Mechanisms and Therapy (6 papers)Liver Disease Diagnosis and Treatment (5 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Wenchang Yu
16 papers receiving 163 citations
Peers
Comparison fields: 5 of 46
- Hepatology 113
- Pathology and Forensic Medicine 60
- Pulmonary and Respiratory Medicine 46
- Surgery 40
- Oncology 35
Countries citing papers authored by Wenchang Yu
This map shows the geographic impact of Wenchang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenchang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenchang Yu more than expected).
Fields of papers citing papers by Wenchang Yu
This network shows the impact of papers produced by Wenchang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenchang Yu. The network helps show where Wenchang Yu may publish in the future.
Co-authorship network of co-authors of Wenchang Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Wenchang Yu. A scholar is included among the top collaborators of Wenchang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenchang Yu. Wenchang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 4 | |
| 7 | 7 | |
| 8 | 1 | |
| 9 | 0 | |
| 10 | 8 | |
| 11 | 8 | |
| 12 | 6 | |
| 13 | 3 | |
| 14 | 4 | |
| 15 | 21 | |
| 16 | 2 | |
| 17 | 38 | |
| 18 | 3 | |
| 19 | 41 | |
| 20 | [Efficacy of transcatheter arterial chemoembolization combined thalidomide on hepatocellular carcinoma: a controlled randomized trial]. | 10 |
About Wenchang Yu
Wenchang Yu is a scholar working on Hepatology, Pathology and Forensic Medicine and Computational Theory and Mathematics, having authored 23 papers that have together received 166 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cancer Mechanisms and Therapy (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). The work is most often cited by research in Hepatology (113 citations), Pathology and Forensic Medicine (60 citations) and Cancer Research (27 citations). Wenchang Yu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Chuanben Chen, Xiaolong Wang, Hui Wu, Qiang Chen, Bo Yuan, Hailan Lin, Zhiwei Yan, Naijian Ge, Chang Fang and Z. Kevin Weng. Their work appears in journals such as Nature Communications, Scientific Reports and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.